Delivery Order SPE2DB22D1106-SPE2DB24FEJT0

Award Date 4/3/24
Potential Completion Date 4/4/24
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of COMIRNATY 2023-24 (12Y UP) syringes (0.3 ML). The order has a potential value of $2,988.60 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. As a major pharmaceutical distributor, Amerisourcebergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $73,350 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The award is for the supply of COMIRNATY 2024-25 (12 years and up) syringes, 0.3 mL, with an ultimate completion date of September 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, under which...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COMIRNATY vaccine syringes (0.3mL) for recipients aged 12 and up. The $3,735.75 order has a completion date of February 5, 2024 and was awarded on February 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order which is not set aside. The company also holds an indefinite...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COMIRNATY 2023-24(12Y UP) SYRG 0.3ML pharmaceutical products. The contract has a completion date of February 26, 2024 and a potential value of $6,363.82. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,934 firm fixed-price delivery order is for the procurement of COMIRNATY 2024-25 (12Y UP) syringes (0.3ML) and has a completion date of November 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The Defense Logistics Agency (DLA) awarded a $14,670 firm fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of 4565938767 COMIRNATY 2024-25(12Y UP) syringes in 0.3ML. This order is part of a larger Indefinite Delivery Contract between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,129.49 firm-fixed-price contract is for the delivery of COMIRNATY 2024-25 (12 years and up) syringes, 0.3 mL. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COMIRNATY 2023-24 (12Y UP) syringes with a 0.3 mL dosage. The contract has a ceiling value of $1,339.98 and a performance period through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under a larger $999,999,999.00 indefinite delivery...
This is a $7,402.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COMIRNATY 2024-25 (12 years and up) syringes (0.3 mL) and has an ultimate completion date of January 15, 2025. This contract is not associated with any set-aside designation. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of COMIRNATY 2024-25 (12Y UP) syringes in 0.3ML size. The contract has a ceiling value of $47,553.90 and an ultimate completion date of September 19, 2024. This delivery order contract is a firm fixed-price arrangement. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEJT0
    Delivery Order

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COMIRNATY 2023-24 (12 and up) syringes (0.3 mL). The $2,009.97 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations were used for this award.

Generated 7/3/24, 10:11 AM